126 related articles for article (PubMed ID: 348479)
1. Vincristine (NSC 67574) in non-small cell bronchogenic carcinoma. Results of a phase II clinical study.
Brugarolas A; Lacave AJ; Ribas A; Miralles MT
Eur J Cancer (1965); 1978 May; 14(5):501-5. PubMed ID: 348479
[No Abstract] [Full Text] [Related]
2. [VP 16-213 in combination with endoxan, methotrexate and oncovin as polychemotherapy for bronchogenic carcinoma].
Ryssel HJ; Hasler E; Sonntag RW; Cavalli F; Martin J; Tschopp L; Brunner KW
Schweiz Med Wochenschr; 1977 Jul; 107(26):912-5. PubMed ID: 877537
[TBL] [Abstract][Full Text] [Related]
3. [Prognostic factors in the chemotherapy of bronchial cancers].
Alberto P
Schweiz Med Wochenschr; 1974 Feb; 104(8):268-71. PubMed ID: 4360755
[No Abstract] [Full Text] [Related]
4. Heparin anticoagulation as adjuvant to chemotherapy in carcinoma of the lung.
Elias EG
J Med; 1974; 5(1):114-32. PubMed ID: 4364885
[No Abstract] [Full Text] [Related]
5. Bronchial artery infusion of mitomycin-C in advanced bronchogenic carcinoma.
Hellekant C; Svanberg L
Acta Radiol Oncol Radiat Phys Biol; 1978; 17(6):449-62. PubMed ID: 83780
[TBL] [Abstract][Full Text] [Related]
6. Combination chemotherapy with methyl-CCNU (NSC-95441), cyclophosphamide (NSC-26271), vincristine (NSC-67574), methotrexate (NSC-740), and bleomycin (NSC-125066) in advanced bronchogenic carcinoma.
McMahon LJ; Jones SE; Durie BG; Salmon SE
Cancer Lett; 1975 Nov; 1(2):97-102. PubMed ID: 65213
[TBL] [Abstract][Full Text] [Related]
7. Combination chemotherapy of bronchogenic carcinoma with cyclophosphamide (NSC-26271) and BCNU (NSC-409962).
Curtis JE
Cancer Chemother Rep; 1974; 58(6):883-8. PubMed ID: 4614897
[No Abstract] [Full Text] [Related]
8. Bleomycin (NSC-125066) followed by cyclophosphamide (NSC-26271), vincristine (NSC-67574), methotrexate (NSC-740), and 5-fllorouracil (NSC-19893) for non-oat cell bronchogenic carcinoma.
Lanzotti VJ; Thomas DR; Holoye PY; Boyle LE; Smith TL; Samuels ML
Cancer Treat Rep; 1976 Jan; 60(1):61-8. PubMed ID: 63331
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy of bronchogenic carcinomas by a combination of cyclophosphamide, methotrexate, vincristin and bleomycin.
Schaerer R; Sotto JJ; Wiget U; Perdrix A; Bensa JC; Ribaud P
Eur J Cancer (1965); 1977; 13(4-5):425-8. PubMed ID: 68881
[No Abstract] [Full Text] [Related]
10. Bleomycin, cisplatin, vincristine, and methotrexate in advanced non-small cell bronchogenic carcinoma.
Rosenthal CJ; Ritter S; Platica O
Cancer Treat Rep; 1982 Jan; 66(1):205-6. PubMed ID: 6171350
[No Abstract] [Full Text] [Related]
11. Phase II evaluation of vindesine in non-small cell bronchogenic carcinoma.
Hutcheon AW; Palmer JB; Pratt MA; Clark RA
Cancer Treat Rep; 1983 Nov; 67(11):1041-2. PubMed ID: 6315231
[No Abstract] [Full Text] [Related]
12. An evaluation of combination chemotherapy with procarbazine (NSC-77213) and 5-fluorouracil (NSC-19893) in advanced carcinoma of the lung.
Gottlieb JA; Serpick AA
Cancer Chemother Rep; 1970 Oct; 54(5):369-71. PubMed ID: 5514626
[No Abstract] [Full Text] [Related]
13. Efficacy study of intensive cis-platin therapy in advanced non-small cell bronchogenic carcinoma.
Vogl SE; Berenzweig M; Camacho F; Greenwald E; Kaplan BH
Cancer; 1982 Jul; 50(1):24-6. PubMed ID: 7044518
[TBL] [Abstract][Full Text] [Related]
14. [Cytostatic therapy of tumors of the lung].
De Marco F; Saviano G; Tenore G
Arch Monaldi; 1974; 29(3-4):326-35. PubMed ID: 4463917
[No Abstract] [Full Text] [Related]
15. Treatment of bronchogenic carcinoma with simultaneous or sequential combination chemotherapy, including methotrexate, cyclophosphamide, procarbazine and vincristine.
Alberto P; Brunner KW; Martz G; Obrecht J; Sonntag RW
Cancer; 1976 Dec; 38(6):2208-16. PubMed ID: 187313
[TBL] [Abstract][Full Text] [Related]
16. cis-Dichlorodiammineplatinum(II), adriamycin, cyclophosphamide, CCNU, and vincristine in non-small cell lung carcinoma: a preliminary report.
Takita H; Marabella PC; Edgerton F; Rizzo D
Cancer Treat Rep; 1979 Jan; 63(1):29-33. PubMed ID: 369692
[No Abstract] [Full Text] [Related]
17. Chemotherapy in bronchogenic carcinoma.
Ojala A; Nikkanen VN; Palojoki A; Paloheimo S
Ann Clin Res; 1977 Feb; 9(1):12-4. PubMed ID: 329741
[TBL] [Abstract][Full Text] [Related]
18. Phase II study of the effect of methyl-CCNU (NSC-95441) on bronchogenic carcinoma.
Takita H; Brugarolas A; Mittelman A; Vincent R
Cancer Chemother Rep 3; 1973 Mar; 4(2):257-9. PubMed ID: 4125743
[No Abstract] [Full Text] [Related]
19. [Bronchial arteriography and intraarterial chemotherapy in bronchogenic carcinoma (author's transl)].
Hellekant C
Radiologe; 1979 Dec; 19(12):521-7. PubMed ID: 229511
[TBL] [Abstract][Full Text] [Related]
20. Phase I-II evaluation of emetine (NSC-33669) in the treatment of epidermoid bronchogenic carcinoma.
Kane RC; Cohen MH; Broder LE; Bull MI; Creaven PJ; Fossieck BE
Cancer Chemother Rep; 1975; 59(6):1171-2. PubMed ID: 1222395
[No Abstract] [Full Text] [Related]
[Next] [New Search]
